Test Module 2

Member States have adopted the global strategy for TB research and innovation through an unprecedented written silence procedure of the 73^rd session of the World Health Assembly (WHA) last week. The global strategy was developed to support efforts by governments and other partners

Roles: Everyone: All Users

Topics: Coronavirus (COVID-19), Global Health, Science, Technology, and Innovation

The second edition provides an improved basis for policy debate and informed decision-making at a critical time for global health.

Roles: Everyone: All Users

Topics: Coronavirus (COVID-19), Economic Prosperity and Trade Policy, Global Health, Human Rights and Democracy, Science, Technology, and Innovation

Snakebite envenoming is a common problem in many parts of the world, but little is known about its magnitude in the Arab countries of the Middle East, where cases are not widely reported. The aim is to halve the numbers of deaths and cases of disability due to snakebite envenoming over the next 12 years through a programme that targets affected communities and their health systems, and by ensuring access to safe, effective treatment through increased cooperation, collaboration and partnership at all leve

Roles: Everyone: All Users

Regions: Jordan , Kuwait , Syria , United Kingdom , Yemen

Topics: Global Health, Refugee and Humanitarian Assistance, Science, Technology, and Innovation

Launching today, the COVID-19 Law Lab initiative gathers and shares legal documents from over 190 countries across the world to help states establish and implement strong legal frameworks to manage the pandemic. The goal is to ensure that laws protect the health and wellbeing of individuals and communities and that they adhere to international human rights standards.

The new Lab (at www.COVIDLawLab.org) is a joint project of United Nations D

Roles: Everyone: All Users

Regions: United Kingdom

Topics: Climate and Environment, Combating Drugs and Crime, Coronavirus (COVID-19), Economic Prosperity and Trade Policy, Global Health, Human Rights and Democracy, Science, Technology, and Innovation

• Seventy-five countries submit expressions of interest to COVAX Facility, joining up to 90 further countries which could be supported by the COVAX Advance Market Commitment (AMC)
• The COVAX Facility, and the AMC within it, is designed to guarantee rapid, fair and equitable access to COVID-19 vaccines for every country in the world, rich and poor, to make rapid progress towards slowing the pandemic 
  
• Interest from governments represen

  Roles: Everyone: All Users

  Regions: Argentina, Canada , Norway , United Kingdom

  Topics: Coronavirus (COVID-19), Global Health, Refugee and Humanitarian Assistance, Science, Technology, and Innovation

• #EndTB Webinar: From Policy to Practice: Rolling out new WHO guidelines on rapid diagnostics and drug-resistant TB treatment

  A special #EndTB Webinar organized by the World Health Organization (WHO) to provide key updates on recently released new WHO guidance on rapid diagnostics and drug-resistant TB treatment. The aim of the webinar is to facilitate better understanding of the guidance to enable its rapid uptake in countries by national programmes and other key stakeholders. This will translate to earlier access to quality diagnosis and treatment, and better outcomes for the millions affected by TB and drug-resistant TB.

  Roles: Everyone: All Users

  Regions: United Kingdom

  Topics: Global Health, Science, Technology, and Innovation

• Addressing the crisis in antibiotic development

  Today, more than 20 leading biopharmaceutical companies are announcing the launch of the AMR Action Fund that will invest in developing innovative antibacterial treatments. The Fund aims to bring 2-4 new treatments to patients by 2030. This initiative is a significant step towards addressing the current crisis in antibacterial treatment development.

  Strengthening accountability to end TB